Search

Search Results

• 

  Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

  M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni

  285-303

  31-03-2015

  Published: 31 March 2015

  2355

  PDF: 2201
• 

  Vitamin D and rheumatic diseases

  M. Rossini, D. Gatti, O. Viapiana, C. Caimmi, L. Idolazzi, E. Fracassi, S. Adami

  153-170

  28-07-2014

  Published: 28 July 2014

  3737

  PDF: 1920

• Vitamin D and fractures: a sistematic review

  O. Viapiana, D. Gatti, M. Rossini, L. Idolazzi, E. Fracassi, S. Adami

  15-19

  Published:

  1325

  PDF: 1527

• Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis

  B. Ristic, C. Bonetto, M. Rossini, E. Fracassi, A. Carletto, S. Tosato

  11-09-2024

  Published: 11 September 2024

  1228

  PDF: 203
• 

  Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

  G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini, A. Fassio

  08-05-2023

  Published: 8 May 2023

  1262

  PDF: 727

• Risk factors for hip fracture in elderly persons

  M. Rossini, A. Mattarei, V. Braga, O. Viapiana, C. Zambarda, C. Benini, S. Pancheri, M.C. Spenevello, R. Lovato, S. Sella, S. Giannini, P. Olivi, F. Lavini, G.M. Giulini, E. Fracassi, D. Gatti, S. Adami

  273-282

  Published:

  2325

  PDF: 4004